Stay updated on Pembrolizumab and Radiotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page
- ChecktodayChange DetectedUI text updates include the addition of glossary toggle options (Show glossary / Hide glossary), capitalization changes to QC-related labels ('Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a revision update from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check8 days agoChange DetectedRevision: v3.3.4 appears at the bottom of the page, replacing v3.3.3, with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check36 days agoChange DetectedAdded a Locations section with California as a study location; removed the California Locations heading. Revision: v3.3.3.SummaryDifference0.2%

- Check58 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed in the page footer, indicating an administrative version update. This change does not affect study details, navigation, or user actions.SummaryDifference0.1%

- Check65 days agoChange DetectedDeleted the administrative notice about potential data delays due to funding lapses and the related links to cc.nih.gov and opm.gov for operating status.SummaryDifference0.4%

- Check87 days agoChange DetectedThe two screenshots show no changes to core content or functionality of the study page; only minor formatting and layout adjustments were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab and Radiotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.